Sign in

CIK 0001653087 · Accelerated filer<br>Smaller reporting company

Alector, Inc.

Sign in to watch
Ticker
ALEC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
822933343
Phone
415-231-5660
Business address
131 OYSTER POINT BLVD., SUITE 600, SOUTH SAN FRANCISCO, CA, 94080
Former names
Alector LLC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$296,087
in 3 filings

Net −$296,087. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Rosenthal Arnon −$193K Chief Executive Officer sold 3% of stake
  2. Berkley Neil Lindsay −$78K CFO & Chief Business Officer sold 8% of stake
  3. Wong-Sarad Grace −$25K Principal Accounting Officer sold 8% of stake
Date Insider Transaction Shares Price Value Owned after
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series A-1 Preferred Stock −94,075 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series A-2 Preferred Stock −4,282,288 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series A-2 Preferred Stock −992,437 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −2,029,626 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series B Preferred Stock −470,374 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −2,280,479 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series C Preferred Stock −528,510 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series D Preferred Stock −1,012,282 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series D Preferred Stock −234,601 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series E Preferred Stock −266,437 0
2019-02-11 ORBIMED ADVISORS LLC Director Conversion · Series E Preferred Stock −85,295 0
2019-02-11 LAVIGNE LOUIS J JR Director Conversion +10,552 10,552
2019-02-11 LAVIGNE LOUIS J JR Director Conversion · Series E Preferred Stock −10,552 0
2019-02-11 Wehner David M. Director Conversion +24,621 24,621
2019-02-11 Wehner David M. Director Conversion · Series E Preferred Stock −24,621 0
2019-02-11 GORDON CARL L Director Conversion +405,925 405,925
2019-02-11 GORDON CARL L Director Conversion +4,282,288 4,688,213
2019-02-11 GORDON CARL L Director Conversion +2,029,626 6,717,839
2019-02-11 GORDON CARL L Director Conversion +2,280,479 8,998,318
2019-02-11 GORDON CARL L Director Conversion +1,012,282 10,010,600

Page 34 of 36 · 702 trades